In an in-vivo oral mucositis model, the microneedle system accelerated mucosal healing, normalized inflammatory and angiogenic markers (VEGF, TNF-α, NF-κB, and IL-10), and achieved nearly complete ulcer recovery when compared to standard treatments. The gene discussed is VEGFA; the disease is ulcer disease.